Navigation Links
MarketsandMarkets: API Market is Expected to Reach $159.08 Billion by 2016

DALLAS, December 6, 2011 /PRNewswire/ --

The report "Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016)" analyzes and studies the major market drivers, restraints, and opportunities in regions such as North America, Europe, Asia, Japan and Rest of the world.

Browse market data tables and in-depth TOC on Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016).
Early buyers will receive 10% customization on reports.

The overall API market was valued at $101.08 billion in 2010, and is expected to grow at a CAGR of 7.9% till 2016.

The API market is facing a period of unprecedented growth as market dynamics have undergone a major change with the expiration of patents pertaining to global best-seller drugs in the U.S. The consequences of the economic crisis has hit the Innovative drugs market hard, with less budgets allocated by the major players for the R&D of Innovative drugs. This has led to drying up of pipelines for new drugs, and therefore the market for generic drugs is quickly growing. Thus, the patent expiry factor is slated to drive the API market for the coming years. At the same time, the governments of developed countries are promoting the use of generics as it reduces the total healthcare expenditure of the respective country.

North America accounts for the highest API Market [ ]; with share of 32% in 2011; and is expected to decrease to 27% by the year 2016. Europe accounts for 31% of the total API market and is expected to decrease to 29% by the year 2016. Moreover, Asia accounts for 26% market share as of the year 2011 and is expected to grow to 34% by the year 2016.

The HPAPI market is driving the API market growth globally at a fast rate. As these compounds are extremely effective in the treatment of cancers, respiratory disorders, and hormonal imbalances, the HPAPIs market is mostly driven by the growth in the oncology therapeutics market worldwide. The global HPAPI market is valued at $8,900 million in 2011; and is expected to grow at a CAGR of 8.3% from 2011 to 2016.

The major players in the market include Teva Pharmaceuticals Ltd (Israel), Sandoz (Switzerland) (Generic Subsidiary of Novartis), Lonza Group AG (Switzerland), DSM (The Netherlands), Dr. Reddy's Lab Ltd (India), and Boehringer Ingelheim GmbH (Germany).

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical, pharmaceuticals [ ], semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website

Mr. Rohan
7557 Rambler Road,
Suite 727, Dallas, TX 75231
Tel: +1-888-6006-441
MarketsandMarkets Blog @

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets: Global Orthopedic Devices Market Expected to Reach $57.9 Billion by 2016
2. MarketsandMarkets: Year 2008 Recorded Highest Number of Clinical Trials (10,326) during the Study Period (2007-2010)
3. MarketsandMarkets: Global Fetal and Neonatal Care Equipment Market Forecast (2011-2016)
4. MarketsandMarkets: "Radiopharmaceuticals for Therapy and PET/SPECT Imaging" Market to reach $4,734 Million by 2015
5. MarketsandMarkets: Global Diagnostic Imaging Market Estimated to Reach $26.6 Billion by 2016
6. MarketsandMarkets: Global Top 10 Medical Devices Market (2010 - 2015)
7. MarketsandMarkets: Lung Cancer Surgery Market (Devices & Treatment Outlook) to be US$ 46.5 Billion by 2015
8. MarketsandMarkets: Global Top 10 Drug Discovery Technologies Market to be $54 Billion by 2015
9. MarketsandMarkets: Global Minimally Invasive Surgery (MIS) Market Worth US$ 90.4 Billion by 2015.
10. MarketsandMarkets: Magnetic Resonance Imaging (MRI) Global Market Worth US$ 5,844.4 Million By 2015
11. MarketsandMarkets: Patient Monitoring Devices Markets in Brazil, Russia, India and China Worth $2,992 Million by 2015
Post Your Comments:
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):